Evaluating HeartWatch Device Versus Conventional Holter Monitor for Detecting Cardiac Arrhythmias with Extended Upper Arm Monitoring

What this Trial Is About

Heart rhythm disorders such as atrial fibrillation, atrial flutter, supraventricular tachycardia, bradycardia, and ventricular arrhythmias are common and can significantly affect patients lives. Detecting these irregular heartbeats can be challenging with current monitoring methods, which are either short-term or invasive. The HeartWatch device is a new, longer-term monitoring system worn on the upper arm that pairs with a smartphone app to help correlate symptoms with heart rhythm data. This study compares the HeartWatch device with the conventional Holter monitor by having patients wear both devices simultaneously. Researchers will collect and compare heart signal data, evaluate the accuracy of autodetection algorithms, assess adverse events related to both devices, and gather patient preferences. The HeartWatch is worn on the left upper arm and transmits data through an app, while the Holter monitor is the standard device used for comparison. Participants will wear both devices for a period of 24 to 48 hours during which researchers will monitor QRS signal detection and analyze ECG parameters such as PR and QRS intervals. Data will be securely uploaded and evaluated to compare device performance. The study aims to provide insight into the reliability, safety, and patient experience of extended cardiac monitoring using these two devices.

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch